A Study in Participants With Type 1 Diabetes Mellitus
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is:
- To compare the blood sugar control of LY2605541 with insulin glargine after 78 weeks of
treatment.
- To compare the rate of night-time low blood sugar episodes on LY2605541 with insulin
glargine during 78 weeks of treatment.
- To compare the number of participants on LY2605541 reaching blood sugar targets without
low blood sugar episodes at night to those taking insulin glargine after 78 weeks of
treatment.
- To compare the rate of hypoglycemia episodes on LY2605541 with insulin glargine during
78 weeks of treatment.